SynthesisInternational journal of clinical oncology2026
Olaparib maintenance versus placebo or standard of care in ovarian cancer: a biomarker-driven systematic review and meta-analysis of randomized trials.
Farida Namozova et al.PubMed ↗Publisher ↗
No numbers read from the abstract.